Suppr超能文献

良性和恶性妇科疾病中四种肿瘤标志物和三种急性期反应物血清水平的围手术期及术后变化

Peri- and postoperative changes in serum levels of four tumor markers and three acute phase reactants in benign and malignant gynecological diseases.

作者信息

Avall-Lundqvist E, Sjövall K, Hansson L O, Eneroth P

机构信息

Department of Obstetrics and Gynecology, Karolinska Hospital, Stockholm, Sweden.

出版信息

Arch Gynecol Obstet. 1992;251(2):69-78. doi: 10.1007/BF02759914.

Abstract

Serum levels of squamous cell carcinoma antigen, carcinoembryonic antigen, CA 125, tissue polypeptide antigen, CRP, alpha 1-antitrypsin and haptoglobin were determined peri- and postoperatively in patients undergoing surgery for benign gynecological disease (n = 18) and postoperatively in women operated for cervical carcinoma (n = 23). The only significant changes seen after premedication, during anesthesia and during surgery were a decrease in serum concentrations of alpha 1-antitrypsin and haptoglobin. We found no postoperative changes in the serum levels of squamous cell carcinoma antigen nor in carcinoembryonic antigen values. However, the latter analyte was influenced by smoking habits. Elevated levels of CA 125 and tissue polypeptide antigen were found in the cancer patients, predominantly within the first 1-3 weeks after surgery. These levels decreased to normal values within 4-6 weeks postoperatively. The median intraindividual coefficients of variation for the tumor markers ranged between 15% and 28% in 30 control women not having surgery. In general, it would seem advisable to wait 6 weeks after surgery before monitoring with CA 125 and TPA is started.

摘要

对接受良性妇科疾病手术的患者(n = 18)在围手术期和术后测定血清鳞状细胞癌抗原、癌胚抗原、CA 125、组织多肽抗原、CRP、α1 -抗胰蛋白酶和触珠蛋白水平,并对接受宫颈癌手术的女性患者(n = 23)在术后进行测定。术前用药、麻醉期间和手术期间观察到的唯一显著变化是血清α1 -抗胰蛋白酶和触珠蛋白浓度降低。我们发现鳞状细胞癌抗原的血清水平以及癌胚抗原值在术后没有变化。然而,后一种分析物受吸烟习惯影响。癌症患者中发现CA 125和组织多肽抗原水平升高,主要在术后1 - 3周内。这些水平在术后4 - 6周内降至正常。30名未接受手术的对照女性中,肿瘤标志物的个体内中位数变异系数在15%至28%之间。一般来说,似乎建议在术后6周后再开始用CA 125和TPA进行监测。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验